J&J CEO Won't Take Stand In Risperdal Breast-Growth Trial

Law360, Philadelphia (September 20, 2012, 7:32 PM EDT) -- Johnson & Johnson CEO Alex Gorsky will not be forced to take the stand in a trial set to begin Monday alleging a boy developed breasts after being treated with the antipsychotic drug Risperdal, a Pennsylvania state judge ruled Thursday.

Judge Arnold New of the Philadelphia Court of Common Pleas granted a motion from J&J division Janssen Pharmaceuticals Inc., agreeing to quash a subpoena directed at Gorsky by attorneys for the teenage plaintiff.

The teenager’s case, one of more than 80 pending in the court, accuses...
To view the full article, register now.